Table 2.
Quantification of PICALM and AP180 in the neural retina
| Protein (pmol/mg tissue protein)a | ||||||
|---|---|---|---|---|---|---|
| Donor ID | #12 | #13 | #17 | #20 | #32 | #39 |
| PICALM+AP180 | ||||||
| Q1 | 2.2 ± 0.3 | 2.5 ± 0.9 | 2.4 ± 0.3 | 2.6 ± 0.3 | 1.7 ± 0.3 | 2.5 ± 0.4 |
| consensus | 2.2 ± 0.4 | |||||
| PICALM | ||||||
| Q3 | 0.73 ± 0.31 | 0.51 ± 0.09 | 0.56 ± 0.18 | 0.45 ± 0.14 | 0.39 ± 0.13 | 0.71 ± 0.12 |
| Q4 | 0.42 ± 0.15 | 0.45 ± 0.13 | 0.31 ± 0.06 | 0.51 ± 0.25 | 0.33 ± 0.06 | 0.54 ± 0.21 |
| consensus | 0.47 ± 0.13 | |||||
a
The concentration was calculated for three biological replicates by monitoring three transitions per individual peptide and presented as mean ± SD. For the consensus, the data for Q1 from different donors and data for Q3 and Q4 from different donors were combined and presented as mean ± SD. The monitored transitions are summarized in Supplementary Table S2.